Ashwin Kishtagari
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Ashwin Kishtagari
May 12, 2024, 01:40 |
Insight
Justin Watts: A significant portion of patients at the extremes of older age (80-90) still derive benefit from the VEN-HMA regimen
Justin Watts et al. report that standard of care treatment for acute myeloid leukemia extends…
Apr 11, 2024, 13:56 |
Blog
Ashwin Kishtagari: A case with distinct bone marrow findings associated with a noncanonical UBA1 variant
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X/Twitter: "We report a…
Mar 26, 2024, 09:53 |
Blog
Manni Mohyuddin: Dr. Tefferi's advice is so REFRESHING and AUTHENTIC
Manni Mohyuddin, Assistant Professor at the Huntsman Cancer Institute, University of Utah, recently posted on…
Jan 19, 2024, 18:33 |
Blog
Ashwin Kishtagari: CHIP mutation zygosity and risk to hematologic malignancies
Ashwin Kishtagari, Assistant Professor at Vanderbilt-Ingram Cancer Center, shared a post on X/Twitter: "Happy to share…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube